About Targeted Therapy Zydelig (Idelalisib)

FDA approved Zydelig (Idelalisib) is a targeted therapy cancer treatment for various types of blood cancers that have relapsed., such as lymphocytic leukemia. Dr. Stephen Lemon, a medical oncologist, describes how this treatment works, as well as what types of side effects it may cause.

Zydelig is a cancer treatment developed by Gilead. Dr. Lemon is medical oncologist who is not affiliated with Gilead.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email